Abstract
A retrospective, subset analysis of the prospective Menopause Study Group data was performed to determine the effects of four conjugated estrogens (CE) + medroxyprogesterone acetate (MPA) regimens and one unopposed CE regimen on the lipid profiles of women with abnormal lipid levels (n = 525). Previously unpublished data on the entire study population were also reviewed to determine the effects of these hormone replacement regimens on blood pressure and weight (n = 1368, 1374, respectively). During a 1-year, prospective trial, all patients took CE. Groups A and B also took continuous MPA 2.5 and 5 mg, respectively, C and D took MPA 5 and 10 mg for the last 14 cycle days of each 28-day cycle, and E took matching placebo tablets to replace MPA. After 1 year, all five regimens were directly associated with significant elevations in high density lipoprotein-2 (HDL2) cholesterol and significant reductions in low density lipoprotein (LDL) cholesterol (p < 0.05), although unopposed estrogen produced the greatest increase in HDL2 cholesterol. The CE + MPA regimens were also associated with significant decreases in total cholesterol. Triglyceride levels did not change significantly from baseline in any treatment group (baseline values >...Continue Reading
References
Oct 1, 1992·British Journal of Obstetrics and Gynaecology·M FalkebornT Naessén
Sep 12, 1991·The New England Journal of Medicine·M J StampferC H Hennekens
Jan 1, 1991·Archives of Internal Medicine·B E HendersonR K Ross
Jan 1, 1991·The American Journal of Medicine
Feb 1, 1991·American Journal of Obstetrics and Gynecology·P H WolfJ C Kleinman
Apr 10, 1991·JAMA : the Journal of the American Medical Association·E Barrett-Connor, T L Bush
Dec 1, 1990·British Journal of Obstetrics and Gynaecology·K HuntK McPherson
Jan 1, 1990·Annals of the New York Academy of Sciences·R A Lobo
Dec 1, 1990·Archives of Internal Medicine·J M SullivanD M Mirvis
Aug 1, 1988·American Journal of Obstetrics and Gynecology·B E HendersonR K Ross
Jun 1, 1987·Circulation·T L BushB M Rifkind
Jun 1, 1986·American Journal of Obstetrics and Gynecology·B E HendersonT M Mack
Feb 28, 1981·Lancet·C ChristiansenI Transbøl
May 1, 1982·Clinical Endocrinology·G F JensenI Transbøl
Jan 18, 1995·JAMA : the Journal of the American Medical Association
Jun 27, 1994·Archives of Internal Medicine·B M PsatyE H Wagner
Apr 14, 1994·The New England Journal of Medicine·P E Belchetz
Jan 1, 1993·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·W M Hern
Apr 29, 1993·The New England Journal of Medicine·M H CriquiC E Davis
May 1, 1993·The Clinical Investigator·M RiedelP Lichtlen
Citations
Apr 1, 2014·Fertility and Sterility·S Mitchell Harman
May 28, 2008·Gender Medicine·Sharon Silbiger, Joel Neugarten
May 5, 2000·The Cochrane Database of Systematic Reviews·R J NormanM C Rees
Mar 5, 2003·Advances in Renal Replacement Therapy·Sharon R Silbiger, Joel Neugarten